Comparative Effectiveness of the Bivalent (Original/Omicron BA.4/BA.5) mRNA COVID-19 Vaccines mRNA-1273.222 and BNT162b2 Bivalent in Adults with Underlying Medical Conditions in the United States

Background/Objectives: This retrospective cohort study evaluated the relative vaccine effectiveness (rVE) of two bivalent (original/Omicron BA.4/BA.5) vaccines mRNA-1273.222 versus the BNT162b2 Bivalent in preventing COVID-19-related outcomes in adults with underlying medical conditions associated w...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Hagit Kopel, Van Hung Nguyen, Alina Bogdanov, Isabelle Winer, Catherine Boileau, Thierry Ducruet, Ni Zeng, Jessamine P. Winer-Jones, Daina B. Esposito, Mary Bausch-Jurken, Ekkehard Beck, Machaon Bonafede, James A. Mansi
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2024-09-01
Saila:	Vaccines
Gaiak:	COVID-19 vaccine mRNA-1273 BNT162b2 high risk comorbidities
Sarrera elektronikoa:	https://www.mdpi.com/2076-393X/12/10/1107
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!